RISW2025
Back to all people

Philip He

Daiichi Sankyo Inc.
3 appearances in the program

Sessions & presentations

PS41: Overcoming Obstacles in Using Hybrid Controls in Phase 2/3 Clinical Trials as the Basis for Regulatory Approval
Presentation: Bayesian Hybrid Design in Early Phase Oncology Clinical Trials for Combination Therapy Development
Parallel · Fri, Sep 26 , 1:30 PM
Presenting Author
Poster Session I
Presentation: 10: Bayesian Basket Trial Design in Early Oncology: A Practical Local Power Prior Framework
Posters · Thu, Sep 25 , 5:45 PM
CoAuthor
TL10-17 Roundtable Discussions
Presentation: TL10: Tipping Point Analyses for Time-to-Event Endpoints in Regulatory Submissions
Roundtable · Thu, Sep 25 , 11:45 AM
Co-Presenter
↑